Acumen Pharmaceuticals, Inc.
ABOS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001576885
No open-market purchases or sales by Acumen Pharmaceuticals, Inc. insiders were filed in the last 90 days; 96 institutions reported holding it in 13F filings for Q2 2026, worth $127.8M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Acumen Pharmaceuticals, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 67 | 80 | +13 |
| Shares | 38.4M | 43.4M | +4.93M (+12.8%) |
| Value | $147.6M | $175.6M | +$28.0M (+18.9%) |
New holders (24)
Institutions that held Acumen Pharmaceuticals, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (11)
Institutions that held Acumen Pharmaceuticals, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| D. E. Shaw & Co., Inc. | 138,029 | $530.0K |
| Acadian Asset Management LLC | 91,496 | $350.0K |
| 683 Capital Management, LLC | 78,431 | $301.2K |
| Caption Management, LLC | 40,000 | $153.6K |
| Virtu Financial LLC | 23,787 | $91.0K |
| Simplex Trading, LLC | 21,422 | $82.0K |
| Occudo Quantitative Strategies LP | 16,929 | $65.0K |
| Global Retirement Partners, LLC | 2,000 | $7.26K |
| Cutler Group LP | 1,200 | $4.00K |
| Advisory Services Network, LLC | 1,000 | $3.84K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 413 | $1.59K |